Enoblituzumab Biosimilar – Research Grade
ichorbio’s Enoblituzumab Biosimilar for Research Use Only (RUO) and not for therapeutic use.
ichorbio’s Enoblituzumab Biosimilar is available in the following sizes:
5mg, 10mg, 20mg, 50mg
Human IgG1(K214R/L235V/ F243L/R292P/Y300L/P396L)-Kappa
Uses the same sequence as the therapeutic antibody Enoblituzumab
Detects human CD276. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Enoblituzumab.
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Sterile, preservative-free, solution in PBS. BSA and Azide free.
>95% by SDS-PAGE
≤ 1.0 EU/mg as determined by the LAL method
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
This biosimilar is strictly for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.